HN-0001
/ HelixNano
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 02, 2024
A study to test the safety of HN-0001 SARS-CoV-2 'COVID-19' Vaccine in Healthy Adults - Cohort 3
(ANZCTR)
- P1 | N=20 | Withdrawn | Sponsor: HelixNano Australia Pty Ltd | Not yet recruiting ➔ Withdrawn
Trial withdrawal • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
June 14, 2024
A study to test the safety of HN-0001 SARS-CoV-2 'COVID-19' Vaccine in Healthy Adults - Cohort 3
(ANZCTR)
- P1 | N=20 | Not yet recruiting | Sponsor: HelixNano Australia Pty Ltd
New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1